Vismodegib in basal cell carcinoma. [electronic resource]
Producer: 20121023Description: 459-67 p. digitalISSN:- 1699-3993
- Anilides -- adverse effects
- Animals
- Antineoplastic Agents -- adverse effects
- Carcinoma, Basal Cell -- drug therapy
- Drug Interactions
- Drug Resistance, Neoplasm
- Evidence-Based Medicine
- Humans
- Pyridines -- adverse effects
- Signal Transduction -- drug effects
- Skin Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.